Finally, we investigated how the administration of CpG-proBs affected the T follicular regulatory (Tfr) to T follicular helper (Tfh) cell ratio (Tfr/Tfh), which is key in controlling the CD4+ T-B cell interaction taking place in GVHD. This evidence concerns the gene CD4 and graft versus host disease.